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Key Points: 
 
 Circular RNAs are hugely enriched in platelets compared to nucleated cell types  
 Lack of enrichment in megakaryocte progenitors implicates degradation of platelet linear 
RNAs 
 
 
 
ABSTRACT 
 
In platelets, splicing and translation occur in the absence of a nucleus. However, the integrity 
and stability of mRNAs derived from megakaryocyte progenitor cells remain poorly quantified on a 
transcriptome-wide level. As circular RNAs (circRNAs) are resistant to degradation by exonucleases, 
their abundance relative to linear RNAs can be used as a surrogate marker for mRNA stability in the 
absence of transcription. Here we show that circRNAs are enriched in human platelets 17-188 fold 
relative to nucleated tissues, and 14-26 fold relative to samples digested with RNAseR to selectively 
remove linear RNA. We compare RNAseq read depths inside and outside circRNAs to provide in silico 
evidence of transcript circularity, show that exons within circRNAs are enriched on average 12.7X in 
platelets relative to nucleated tissues, and identify 3162 genes significantly enriched for circRNAs, 
including some where all RNAseq reads appear to be derived from circular molecules. We also 
confirm that this is a feature of other anucleate cells through transcriptome sequencing of mature 
erythrocytes, demonstrate that circRNAs are not enriched in cultured megakaryocytes, and that 
linear RNAs decay more rapidly than circRNAs in platelet preparations. Collectively, these results 
suggest that circulating platelets have lost over 90% of their progenitor mRNAs, and that translation 
in platelets occurs against the backdrop of a highly degraded transcriptome. Finally, we find that 
transcripts previously classified as products of reverse transcriptase template switching are both 
enriched in platelets and resistant to decay, countering the recent suggestion that up to 50% of 
rearranged RNAs are artifacts.  
 
 
  
3 
 
INTRODUCTION 
Platelets are small, anucleate, circulating blood cells derived from polyploid megakaryocyte 
progenitors 1 and are vital for functions such as hemostasis, wound healing and angiogenesis 2. 
Unlike anucleate erythrocytes which have a lifespan of ~4 months and have greatly reduced 
ribosome numbers 3, platelets are short lived (~8-11 days 4), translationally competent 5, and a 
number of genes have been shown to undergo cytoplasmic splicing upon platelet activation 6,7. 
Consistent with these observations, recent RNAseq analyses have defined a complex platelet 
transcriptome 8-11. However, some transcripts believed to contribute to platelet function are present 
at very low levels in RNAseq data 11, and attempts to integrate transcriptome and proteome data 
have given conflicting results 12-15. In the absence of nuclear transcription, RNAs within platelets are 
assumed to degrade over time. Although the abundance of individual mRNAs has been shown to fall 
in platelets at ambient temperatures 16, the stability and integrity of mRNAs within circulating 
platelets is poorly characterised at the transcriptome level. However, this is highly relevant to 
functional inferences drawn from RNAseq data 9,11,15,17,18. 
Transcripts with rearranged exon order are now known to be common in eukaryotic 
organisms, and are characterised by “back-splice” exon junctions inconsistent with the underlying 
genomic DNA 19-24. Evidence for linear and polyadenylated structures has been presented 20,25,26, but 
it is now clear that most are circular (circRNAs) and cytoplasmic 21-23. Recent experiments have 
established that intronic repeats flanking rearranged exons can promote circularisation, and that 
circRNAs primarily utilise canonical splice sites 27-30 and can be regulated by RNA binding proteins 29,31. 
Although two non-coding circRNAs act as miRNA sponges 22,26, and circRNAs with retained introns 
(Exon-Intron or EIcircRNAs) can enhance transcription of their parental genes through interaction 
with U1 snRNP and RNA PolII 32, the vast majority of circRNAs consist of exons from protein encoding 
genes and have no known function 22,33.  
Circular RNAs are resistant to attack by exonucleases involved in the regulation of mRNA 34 
and resistance to one, RNAseR, has been used to define them 23,35. Furthermore, blocking of 
transcription can increase circRNA levels relative to linear 23. This differential stability raises the 
possibility that abundance of circRNAs relative to linear forms could provide insight into the platelet 
transcriptome. Here, we analyse the circRNA population of platelets, and compare it to populations 
in nucleated cells, anucleate erythrocytes, and cells where linear RNA has been digested with 
RNAseR. We show that circRNAs are highly enriched in both platelets and erythrocytes relative to 
nucleated tissues, and confirm this experimentally using qPCR. We identify over 3000 genes where 
circRNAs are significantly enriched relative to nucleated cell types, including some genes where only 
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circRNAs producing exons are represented within the RNAseq data. We also use qPCR to establish 
that circRNAs are not enriched in cultured magakaryocytes and that, over time, the levels of linear 
RNAs fall relative to circRNAs in platelet preparations. Our results suggest that over 90% of mRNAs 
have been lost from circulating platelets, and have potentially important implications for both 
platelet biology and our understanding of circRNAs. 
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MATERIAL AND METHODS 
Datasets used 
In silico analyses were performed on RNAseq data generated during this study and on 36 
publicly available datasets: 24 ribosomal RNA depleted total RNA samples sequenced on the Illumina 
platform 11,23,27,36,37, 2 polyA+ selected samples sequenced on the Ilumina platform 11,38, and 10 non-
ribosomal RNA depleted total RNA samples sequenced on the SOLiD platform 15. For details, see 
Supplementary Methods and Supplementary Table S1. 
 
Erythrocyte RNAseq 
Ribosome depleted RNAseq of total RNA from red blood cells was performed by AROS 
Applied Biotechnology (Aarhus, Denmark) using the TruSeq RiboZero Stranded mRNA LT kit 
(Illumina). The library was sequenced using a paired-end 100 base pair protocol according to 
manufacturer’s recommendations (see Supplementary Methods).   
 
circRNA identification 
Identification of back-splice exon junctions was performed using PTESFinder Pipeline v. 1 
(http://sourceforge.net/projects/ptesfinder-v1/). This identifies RNAseq reads which map in inverted 
order but the same orientation to the same RefSeq entry, generates sequence models of back-splice 
junctions, and re-maps all reads to the models. It then removes reads which do not utilise known 
exon junctions, or which map equally well or better to the genomic or transcriptome reference (see 
Supplementary Methods and Supplementary Figure S1 for details). 
 
Biological samples: origin and preparation 
Tissue RNAs were obtained from Biochain (Amsbio, UK). Red blood cells were obtained from 
the Scottish National Blood Transfusion Service (SNBTS) in accordance with the terms of the 
standard donor consent form and information, and with approval of the SNBTS Sample Governance 
Committee. Cord blood was obtained after informed consent under a protocol approved by the 
National Research Ethics Service (Cambridgeshire 4 Research Ethics Committee ref. No. 
07/MRES/44).  Whole blood samples were collected from healthy volunteers with approval from 
Newcastle University’s Faculty of Medical Sciences Ethics Committee.  Platelets and platelet rich 
plasma (PRP) were isolated according to a protocol which utilises a platelet inhibitory cocktail 39. 
Isolation of peripheral blood mononuclear cells (PBMCs) and red blood cells (RBCs) was performed 
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using Histopaque-1.077 density gradients (Sigma-Aldrich). Megakaryoctes were cultured and 
isolated according to the protocol of Tijssen et al 40. For further details see Supplementary Methods. 
 
RNA isolation and cDNA generation 
RNA was isolated using Trizol (Lifetechnologies) and treated with DNase I (Promega) 
according to manufacturer’s instructions. RNA quantitation was performed using the NanoDrop ND-
1000 spectrophotometer (Thermo Scientific) and quality was assessed using the Agilent 2100 
Bioanalyser (Agilent Technologies). cDNA was synthesised using high capacity cDNA kits (Applied 
Biosystem), random hexamers, and Moloney murine leukaemia virus (MMLV) unless stated 
otherwise.  
 
Real time PCR 
Real time PCR was performed using Taqman mastermix (Lifetechnologies) as described 
previously 20. Primers and assay efficiencies are given in Supplementary Table S2. Transcript 
expression was normalized using the ∆CT method relative to the geometric mean of 4 housekeeping 
genes (GAPDH, PPIA, TUBB, GUSB) analysed using TaqMan gene expression assays (Applied 
Biosystems). Circular transcripts were also normalized against the linear transcript from the same 
gene where appropriate. The Wilcoxon rank sum test was used to compare levels of circRNA v linear 
RNA across multiple structures (analysis of paired –Ct values), and to compare linear v circRNA 
expression ratios between conditions or sample types (analysis of –Ct values across all structures). 
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RESULTS 
Platelets are highly enriched for circRNAs 
We first identified 3 publicly available RNAseq datasets from human platelets 9,11,15,  one of 
which had a sequence read length long enough for the identification of back-splice junctions within 
circRNAs and included samples processed to retain unpolyadenylated RNAs (Array express i.d. E-
MTAB-1846; 100bp Illumina ribosome depleted total RNAseq from 3 individuals, and polyA+ RNAseq 
from 1 individual 11). Analysis of the 3 total RNAseq samples using a back-splice exon junction 
discovery pipeline (PTESFinder, see Methods) identified 33829 distinct structures consistent with 
circRNAs (Supplementary Figure S1 and Supplementary Table S3), approximately 4-5X more than 
reported for fibroblasts 23 and ~15X more than reported for leukocytes and HEK293 cells 22 in 
libraries of comparable size. Analysis with independent software previously used for identification of 
both genic and non-genic circRNAs 22 also identified an excess in platelets relative to these datasets 
(see Supplementary Figure S1). Furthermore, ~63% of the 33829 structures have previously been 
identified within RNAseq data generated following RNAseR digestion (to selectively remove linear 
transcripts 23,27), consistent with them being circRNAs. Despite the large number identified, the 
majority are not platelet specific, as 24632 (~73%) were also present in one or more of 15 ENCODE 
RNAseq datasets previously mined by Salzman et al. (2013) (Supplementary Figure S1).  
Having identified an apparent abundance of circRNAs in platelets, we then used PTESFinder 
to identify circRNAs within other publicly available datasets generated using ribosome depleted total 
RNAseq and sequenced using the Illumina platform. These comprised 12 human tissues 37, ENCODE 
cell lines 41, and cell lines treated with RNAseR to selectively remove linear RNAs 23,27. To enable 
comparison with a distinct anucleate cell type, we also generated >120 million 100bp paired-end 
reads from total RNA extracted from leukocyte depleted red blood cells (RBCs, GEO record # 
GSE69192, see methods). Analyses of these data, summarised in Figure 1 and presented in 
Supplementary Table S3, show that 17-188 times more circRNA (back-splice) reads are present in 
platelets than in human nucleated tissues (7579-11138 circRNA junction reads per million reads 
versus 59-447), and 14-26 times more than in samples treated with RNAseR (427-463 junction reads 
per million reads). In addition, the mean numbers of circRNA structures per circRNA producing gene 
are larger in anucleate and RNAseR digested samples than in others, with two of the three platelet 
samples averaging over 5 structures per gene, compared to 1-2 for nucleated tissues and cell lines.  
We also analysed the platelet polyA+ sample from E-MTAB-1846 and identified 841 circRNA 
structures from 453 genes. However, their nucleotide composition was found to be significantly 
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enriched for A residues relative to structures present only in platelet total RNA (Chi squared = 12317 
p<2.2e-16, Supplementary Table S4). As this suggests these structures are non-polyadenylated 
circRNA transcripts rich in A nucleotides, they were not analysed further. 
More than 600 platelet genes generate over 20 distinct circRNAs 
To illustrate the variation in circRNA distributions, the numbers of circRNA structures 
identified per gene are displayed for 4 samples in Figure 2A. Strikingly, both platelets and fibroblasts 
digested with RNAseR (which increases circRNA levels by degrading linear RNAs) have large numbers 
of genes generating >15 distinct circRNA structures. For example, the platelet sample has >600 
genes each with >20 different circRNAs. Furthermore, as shown in Table 1, individual structures in 
anucleate samples are supported by much larger back-splice junction read counts than in nucleated 
tissues (p=2.7x10-4 anucleate v nucleated counts, Wicoxon rank sum test). All 3 platelet samples 
have over 1000 structures supported by over 100 reads, in sharp contrast to undigested nucleated 
samples. As an example of the diversity of structures and read support within platelets, the 49 
circRNA structures identified within the XPO1 gene are shown in Figure 2B, with supporting read 
counts ranging from 1 (E8-E5 and E16-E7) to 4045 (E4-E2). It is noteworthy that all 21 internal exons 
of this gene are encompassed by one or more circRNA (illustrating that most exons within some 
genes can contribute to circRNAs). Only 11 of these structures were identified previously in RNAseR 
digested H9 RNA 27. 
Real Time PCR confirmation of high circRNA transcript levels in anucleate cells  
 To experimentally confirm enrichment of circRNAs in both anucleate cell types, we used 
qPCR to assess relative levels of linear and circRNAs. We first assayed the CD45 antigen (PTPRC) 
which is highly expressed in peripheral blood mononuclear cells (PBMCs), and performed cell counts 
to confirm that PBMCs were being efficiently removed during platelet isolation (Supplementary 
Figure S2 and Supplementary Methods). As a precaution against Reverse Transcriptase (RT) specific 
artifacts 42, we also checked that all circRNAs being analysed could be amplified using templates 
generated with both AMV and MMLV RTs (Supplementary Figure S3). We then analysed the 
abundance of two known circRNA structures from MAN1A2 (E4-E2 and E5-E2 22) relative to the 
canonical MAN1A2 transcript, two structured from PHC3 (a gene expressed in platelets for which 
assays were already available 20), and an additional 7 abundant circRNAs with their associated linear 
RNAs (see Supplementary Table S2). For each, paired assays with a common probe were used (Figure 
3A).  
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Both of the MAN1A2 circRNA junctions are much more abundant in platelets and RBCs than 
the linear mRNA (Figure 3B). However, they are less abundant than the linear transcripts in virtually 
all nucleated tissues analysed. This is consistent with the RNAseq data and previous analyses of 
nucleated tissues 20,22. The other 9 circRNAs are also expressed at higher levels in platelets and RBCs 
than their corresponding linear structures (Figure 3C), with circRNAs from SMARCA5, UBXN7 and 
PNN registering ~6-10 cycles before their corresponding linear RNAs, suggesting they are ~50-1000 
fold more abundant. In contrast, all are expressed in nucleated cells at an equivalent or lower level 
than their linear counterparts. Collectively, the difference in relative expression levels of linear and 
circRNAs between anucleate and nucleated tissues is highly significant (p=2.7x10-12 Wilcoxon rank 
sum test). 
Finally, the impact of RNAseR digestion upon expression was also assessed (Figure 3D). 
Digestion increases the levels of all back-splice junctions relative to the canonical linear junctions in 
each cell type analysed (p=7.8x10-3 Wilcoxon paired rank sum test, mock digest v RNAseR digested), 
although the MAN1A2 E5-E2 back-splice shows only a marginal increase in the platelet sample. This 
confirms that these structures include circRNAs. However, the impact of RNAseR digestion is more 
pronounced in peripheral blood mononuclear cells (PBMC) and in HEK293 cells than in either 
anucleate sample (p<0.02, Wilcoxon paired rank sum test for all pairwise nucleated v anucleated 
comparisons, Figure 3D).  
For some genes, only reads from circRNA producing exons are detected in platelets 
The abundance of individual circRNAs relative to mRNAs from the same loci has previously 
been estimated in silico by comparing back-splice junction read counts to flanking canonical junction 
counts 20,21,43. However, because most circRNA producing genes generate multiple overlapping 
structures (e.g. Figure 2B and Supplementary Table S3), the canonical junctions flanking one circRNA 
are often present within others. We therefore performed a transcriptome-wide analysis where we 
calculated for each gene the RPKM across all exons internal to all known circRNA structures (RPKMI), 
and the RPKM across exons external to all known circRNAs (RPKME). The former is a measure of both 
linear and circRNA expression, the latter linear only. Box and whisker plots showing RPKMI/RPKME 
ratios for all circRNA producing genes in all samples are presented in Figure 4A. The ratios from 
individual genes extend over 6-8 orders of magnitude for each sample, but what is most striking is 
that the median RPKMI/RPKME ratios of the anucleate samples are approximately 12 times higher 
than nucleated tissues, and approximately 5 times higher than samples digested with RNAseR 
(Figure 4A). The distribution of RNAseq reads therefore reflects the pattern of circRNA structures 
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inferred from exon-junction read counts alone (Figures 1 and 2), and provides further evidence that 
back-splice junctions are predominantly derived from circRNAs.  
To identify genes significantly enriched for circRNAs in platelets, we then estimated the 
contribution of circRNA producing exons to total transcription for each gene by calculating 
RPKMI/(RPKMI + RPKME) ratios, and compared ratios in the platelet samples to ratios in the 12 
nucleated tissues using the Wilcoxon rank test (p-value = 0.05, Benjamin and Hochberg false 
discovery rate = 0.01). Out of 8041 circRNA producing genes analysed, 3162 showed significantly 
enriched transcription from circRNA producing exons in platelets (Supplementary Table S5).  When 
the ratios from all genes with an average RPKM >1 in platelets are plotted (Figure 4B), it can be seen 
that for the vast majority of enriched genes the contribution of circRNA exons to total transcription 
is >0.6 in nucleated tissues, but >0.8 in platelets. Furthermore, for 457 genes transcription from 
circRNA producing exons exceeds an average of 99% in the platelet samples, and for 15 genes it is 
100% in all 3 samples (Supplementary Table S5). As this assay is not dependent on exon junction 
counts, which require long sequence reads for accurate detection, we applied it to one of the SOLiD 
platelet RNAseq datasets 15, and confirmed the presence of similar patterns of circRNA exon 
enrichment (e.g. Supplementary Figure S4, and Supplementary Data File 1).  
Reads from circRNA producing exons are enriched in platelets by up to 3000 fold  
To estimate the magnitude of circRNA exon enrichment for each gene in platelets relative to 
other tissues, we further analysed genes with an average RPKMI >1 by normalising their mean 
platelet RPKMI/RPKME ratio against the mean RPKMI/RPKME ratio from all 12 nucleated samples. The 
average enrichment was 12.7X for all genes, and 22X for the 3162 significantly enriched genes, with 
the highest enrichment being 3590X for TMEM181 (Figure 4C and Supplementary Table S5). To 
illustrate these extreme levels of enrichment, RNAseq read counts and circRNA junction read counts 
for 4 enriched genes from a single platelet sample are shown in Figure 5 (panels A-D). The vast 
majority of platelet RNAseq reads from PNN (enrichment 2189X) map to exons 7 and 8 which 
correspond to the most abundant circRNA (Figure 5A); the majority of reads from SLC20A2 
(enrichment 152X) map to the abundant circRNAs involving exons 3-5 (Figure 5B); all reads from 
POMT1 (enrichment 127X) map to exons within its only circRNA (E4-E3 Figure 5C), while for PHC3 
(enrichment 240X), reads map largely to the abundant E6-E5 and E7-E5 structures (Figure 5D).  
Although these in silico analyses point to enrichment specifically in anucleate cells, no total 
RNAseq data has been generated from the direct progenitors of these cells. For all genes with assays 
available, we therefore also analysed the relative levels of linear and circRNAs in megakaryocytes 
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cultured from cord blood. These were harvested after 10 days, when >70% of cells were positive for 
CD41 and CD42 (See Supplementary Methods). The results, presented in Figure 5 panels E and F, 
establish that relative levels of linear and circRNA in megakaryocytes are similar to other nucleated 
cell types (Figure 2B); all circRNAs are expressed at a much lower level relative to linear RNAs than in 
platelets (p=1.4x10-6 Wilcoxon paired rank sum test across all structures). This is consistent with 
circRNA enrichment after platelet formation.  
 
Confirmation of differential decay of linear and circRNAs in platelet preparations  
Human mRNAs are subject to a wide variety of decay pathways 44, and exhibit extensive 
variation in decay rates 45-47. To investigate decay in platelets, we first correlated the change in 
transcript abundance between megakaryocyte PolyA+ RNA and platelet PolyA+ RNA with published 
estimates of mRNA half-life 45. This identified a weak but highly significant correlation, despite the 
difference in cell types between datasets, with short half-life genes showing a more pronounced 
reduction in transcript abundance (r=0.17, p=3.35e-44, Figure 6A). This is consistent with a 
transcriptome-wide role for mRNA decay in platelet expression levels.  
To experimentally investigate differential decay, we then used Real Time PCR to analyse 
changes in linear and circRNA abundance in platelet rich plasma (PRP) over time (see Methods). 
Consistent with previous analyses 16 initial experiments suggested that all transcript levels remained 
stable at 4oC, but that degradation of mRNA could be detected when incubation temperature was 
elevated (data not shown). To assess decay at a physiologically relevant temperature, we assayed 
the relative abundance of linear and circRNAs in PRP from 3 individuals, before and after incubation 
at 37oC for 72 and 96 hours (Figure 6B). The levels of all 4 housekeeping genes were reduced by 
incubation, with CT values increasing by 4-6 cycles (Figure 6B top left panel). Reduction was also 
observed when genes which are highly abundant in platelets were analysed (Supplementary Figure 
S5). Normalization of linear transcripts from circRNA producing genes against the housekeeping pool 
(Figure 6B, top right panel) suggests that there are differences in decay rates between genes, with 
UBXN7, PNN and MAN1A2 transcripts being enriched relative to control housekeeping RNAs. 
Strikingly, however, circRNAs show significant enrichment (2-6 fold) relative to linear RNAs after 
incubation (Figure 6B, lower panel, p<2x10-3 for both day 0 v 72 hours and day 0 v 96 hours, 
Wilcoxon rank sum test across all structures). This confirms that linear structures decay more rapidly 
than circRNAs in platelets.  
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DISCUSSION 
Platelets are anucleate yet retain machinery required for splicing and translation, and there is 
extensive evidence that genes are translated in activated platelets 5-7,48-50. As a result, recent platelet 
transcriptome analyses have generated considerable interest 8,17,18. However, here we have shown 
that the platelet transcriptome is significantly enriched for circRNAs as assayed using back-splice 
junction counts, real-time PCR, and an RNAseq comparative read depth approach. Back-splice reads 
are enriched 17-188 fold relative to nucleated tissues, and over 3000 genes have a statistically 
significant enrichment of reads from circRNA producing exons. Furthermore, for some genes only 
RNAseq reads derived from circRNA producing exons are detected within platelet samples, 
highlighting the impact this enrichment will have upon RNAseq based estimates of expression levels. 
We have also established that circRNAs are not enriched in cultured megakaryocytes compared to 
other nucleated cell types.  
While we cannot formally rule out the possibility that some circRNA enrichment occurs at the 
transcriptional level late in megakaryocyte maturation, collectively our results suggest that 
enrichment occurs specifically in platelets, after the loss of nuclear influence. The similarly high 
levels of enrichment observed in anucleate RBCs are consistent with this, while the observed 
reduction of linear RNAs relative to circRNAs in platelets incubated at 37oC confirms that differential 
decay occurs. The overall level of enrichment of RNAseq reads from circRNA producing exons is 
consistent with platelet mRNA levels being at least 90% lower than within nucleated tissues (average 
enrichment 12.7X for genes with RPKMI>1). Although this is a rough and indirect estimate, it is likely 
to be conservative as it assumes no degradation of circRNAs. Furthermore, the fraction of 
translatable RNAs is likely to be even lower, as our analysis has only considered RNA abundance, not 
structural integrity. This is consistent with the suggestion that platelet lifespan may be determined 
by translational competence 51. 
Degradation has been assumed to be a feature of the platelet transcriptome based purely on 
their anucleate nature 51. Mitochondrially encoded genes are among the most highly expressed 52, 
levels of individual mRNAs have been shown to fall when platelet preparations are incubated at 
ambient temperature 16, and there is some evidence that translation is reduced in aged platelets 
relative to the whole population 51. Consideration of mRNA half lives alone would suggest that mRNA 
degradation is likely to be substantial, unless platelet specific mechanisms exist to counteract it. If 
we assume the average age of circulating platelets is 4 days, then mRNA half-lives 45 would predict 
gene specific reductions in expression ranging from 1.2X to 720X, with a mean reduction of 14X. Our 
estimate of 12.7X based on RNAseq read counts is broadly consistent with this, despite the fact that 
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RPKMI/(RPKMI + RPKME) ratios will vary between genes due to a variety of factors which are 
unrelated to circularity, including differential isoform abundance, overlapping UTRs between 
neighbouring genes, and the reduction in RNAseq read coverage close to transcript termini. 
Extensive mRNA degradation provides a simple explanation for conflicting reports concerning 
the correlation between the platelet transcriptome and proteome 12,13,15,53, and for the presence of 
proteins in platelets without corresponding mRNAs 15,50. It can also explain why many genes shown 
to be spliced and/or translated in platelets, such as Tissue Factor (F3) 7,54, IL1B 55, SLC23A2 56, FGA, 
FGB, FGG, ALB 57, and BCL3 58, are present at very low levels or not at all in some RNAseq datasets 
10,11. Collectively, our results indicate that translation in platelets occurs against the backdrop of a 
rapidly degrading transcriptome, that platelets will differ in their translational potential in an age 
dependent manner, and that RNAseq analyses targeted towards intact species which are capped 15,18 
or polysome bound will be required to analyse translational potential in these cells effectively. 
CircRNAs have been identified from RNAseq data by the back-splice exon junctions they contain, 
and such junctions have been taken prima facie as evidence of circularity 24,33,59,60. Our exon-
partitioned analysis of read-depth provides additional in silico evidence of circularity, as trans-
splicing of independent linear pre-mRNA 20,42 would affect exons both up and downstream of the 
back-spliced exons. The identification of higher numbers of circRNAs in platelets than in total RNA 
digested with RNAseR is, however, surprising and indicates that cessation of transcription in 
platelets leads to more extreme enrichment of circular RNA through differential decay in vivo, than 
enzymatic digestion of linear species in vitro. This could be due both to limitations of RNAseR 
specificity, and the lability of RNA post extraction. The significant enrichment of A nucleotides within 
back-splice transcripts present within platelet polyA+ RNA is also noteworthy as it means their 
presence within oligodT selected RNA fractions does not necessarily imply polyadenylation, as has 
been suggested previously 20,42, and may adversely affect the accuracy of RNAseq based mRNA 
expression estimates of the genes involved. 
It has recently been suggested that up to 50% of RNAs with back-splice exon junctions are 
reverse transcriptase artifacts. This was extrapolated from an analysis of 13 back-splice RNAs where 
the only 6 RNAs which could be independently validated were those which could be amplified using 
both AMV and MMLV reverse transcriptases 42. However, among the 7 RNAs which could not be 
validated, 4 were intragenic back-splice structures and all are present within platelets: The back-
splice counts of 3 (PHC3 E6-E5, CNTLN E5-E3, RERE E3-E3) are enriched relative to other tissues 
(~1000X, ~100X, ~4X), and read counts in exons between each back-splice are also enriched (240X, 
~30X, 500X) indicative of circRNAs. Furthermore, the PHC3 E6-E5 structure degrades more slowly 
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than linear RNA, is resistant to RNAseR digestion 23, and in our hands can be amplified from cDNA 
generated using either MMLV or AMV (Supplementary Figure S3). These diverse lines of evidence 
suggest that there may not be a straightforward relationship between RT-specificity and artifacts as 
previously suggested 42. 
Finally, cellular levels of circRNAs are known to be low in proliferating and neoplastic human 
cells 43,60 but to increase during differentiation of ES cells 26 and during Drosophila development 61, 
suggesting that they may be a biomarker for ageing. Among nucleated tissues they are highest in 
both human and Drosophila neural tissues 43,61 and are particularly enriched in synapses 43. They are 
also enriched in exosomes 62. These observations, together with the presence of miRNA binding sites 
within circRNAs 61 and the dynamic expression patterns of some 43, implies that they may be of 
functional importance. CircRNA levels can be modulated by intronic sequence identity 23,27,28, and 
splicing factors such as Quaking 31 and Muscleblind 29. However, our qPCR analysis of transcripts in 
MKs suggests that the extreme enrichment in platelets reported here is not due to modulation at 
the pre-mRNA level within progenitor cells. With no transcription in platelets it can, therefore, only 
be accounted for by differential degradation/decay. The very high levels of enrichment reported 
here suggests that, even if the relative levels of linear and circRNAs from each gene remain constant 
at the level of transcription, subtle changes in expression level, rates of mRNA export, changes in the 
cell cycle 60, changes in nuclear and cytoplasmic volumes, and distance from the nucleus, could all 
alter relative abundance over time. Many reported differences in linear and circRNA levels could, 
therefore, be due to differences in stability alone. 
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LEGENDS TO TABLES AND FIGURES 
Table 1. circRNA read support for structures and their frequency in all samples. For each sample, 
the number of distinct circRNA structures supported by over 10, 100 and 1000 circRNA (back-splice) 
reads are shown, together with the number of circRNA reads per million reads (K/M). D – Digested 
with RNAseR, U – Undigested, matched sample. 
Figure 1. CircRNAs in human tissues. The number of circRNAs (structure counts), junction reads 
(back-splice read counts), circRNA producing genes (gene counts), mean number of circRNA 
transcripts per circRNA producing genes, and RNAseq library sizes (read counts) are shown. Samples 
are presented as 4 groups: nucleated tissues, nucleated cell lines, nucleated cell lines digested with 
RNAseR, and anucleated cell types. The number of back-splice reads is significantly higher in 
anucleate samples (platelets and RBCs) than all others (p=2.7x104 Wilcoxon Rank Sum test, figures 
adjusted for library size). All data were processed using PTESFinder, and all were publicly available 
with the exception of the data from RBC (see Methods and Supplementary Table S1 for details of 
datasets and Supplementary Table S3 for details of structures). 
Figure 2. CircRNA structures per gene. A. Histograms showing circRNA numbers per gene 
established using PTESFinder for RBCs (this study), Platelets 11, Fibroblasts, and Fibroblasts digested 
with RNAseR 23. B. Schematic diagram showing XPO1 intron/exon organisation with read counts and 
inferred structure of all circRNAs identified within the 3 platelet samples. Inferred structures assume 
that all internal Refseq exons are present within the structure defined by each back-splice. Read 
counts for the 11 structures identified previously within RNAseR digested H9 ES cells 27 are 
highlighted in red. 
Figure 3. Confirmation of circRNA abundance and resistance to RNAseR. A. Schema of qPCR assays 
using an E5-E2 circRNA as an example. All assays use a common reporter probe, and utilise either an 
exon downstream of the circRNA to assay linear expression (probe in donor exon), or an exon 
upstream (probe in acceptor exon). B. Left panel - Expression levels (-∆CT values) of linear (Ex1-2) 
and circular (Ex5-2, and Ex4-2) MAN1A2 transcripts relative to housekeeping pool. Right panel - 
Expression levels of circRNAs relative to linear RNAs from the same loci normalized to housekeeping 
pool (-∆∆CT values). C. Expression of 9 circRNAs relative to linear forms from the same loci, 
normalized to housekeeping pool (-∆∆CT values). D. Change in CT values of circRNAs relative to 
linear forms from the same loci in RNAse digested RNAs, normalized to mock digested RNAs (-∆∆CT 
values). Templates, circRNAs and linear forms assayed are indicated. 
Figure 4. Differential read depth defines genes with significant circRNA enrichment in platelets. A. 
Box and Whisker plots showing the Ratio of RPKM from circRNA producing exons (RPKMI) to RPKM 
from exons which do not produce circRNAs (RPKME) for all genes in each sample. The median, upper 
and lower quartiles are shown, with outliers as solid circles. B. The proportion of reads from circRNA 
producing exons averaged across all nucleated samples (Y axis) and platelets (X axis). C. Fold 
enrichment of reads from circRNA producing exons in platelets relative to nucleated tissues. All 
genes with an average RPKMI >1 in platelets and expressed in 8 or more nucleated tissues are shown. 
Blue – genes significantly enriched in platelets. Red – genes not significantly enriched in platelets. 
The datapoints corresponding to the 5 most enriched genes are indicated. The slope x=y is shown as 
a dashed line. 
Figure 5. circRNA enrichment occurs in platelets but not megakaryocytes. A-D. Adapted UCSC 
screen shots for 4 genes which extreme circRNA enrichment in platelets. Each panel shows RNAseq 
read abundance in a single Platelet total RNA sample (F1), together with the position and abundance 
of back-splice exon junctions in the same sample. The intron-exon structure is shown below, with 
exons known to contribute to circRNAs shown in red. CircRNA structures present in the sample 
together with back-splice frequencies are also shown (for PHC3, only structures with 10 or more 
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back-splice reads are shown). Above each panel, the gene names, cytogenetic locations, coding 
strand, and scale in kilobases are indicated. E-F. Expression levels of circRNAs relative to linear RNAs 
from the same loci in platelets and cultured megakaryocytes, normalized to housekeeping pool (-
∆∆CT values).  
 
Figure 6. Degradation of platelet RNA. A. Correlation of the change in gene expression between 
megakaryocte polyA+ RNA and platelet polyA+ RNA (Y axis), and mRNA half life estimates (X axis). 
Distributions of both are shown as histograms on each axis. B. qPCR analysis of differential decay of 
linear and circRNAs in platelets following incubation at 37oc for 0, 72 and 96 hours. Data from 3 
biological replicates are shown. Top left panel - Expression levels of housekeeping genes (CT values); 
Top right panel - Expression levels of linear structures from 5 circRNA producing genes relative to 
housekeeping pool (-∆CT values); Bottom panel - Expression levels of 7 circRNAs relative to linear 
transcripts from the same loci, both normalized to housekeeping pool (-∆∆CT values). 
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TABLE 1 
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1 
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lood Cells 
>10 55 308 164 136 196 186 71 670 235 263 521 190 3 9 11 6 125 141 227 2797 3052 7281 9605 8459 1272 
>100 0 11 3 2 2 3 1 19 5 3 6 5 0 0 0 0 4 2 2 200 224 1197 1686 1325 96 
>1000 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 2 5 83 147 95 2 
K/M 66 295 170 69 104 126 59 447 148 125 172 84 9 7 9 9 45 36 427 546 464 8469 11138 7579 597 
 
 
 






